Revolution Medicines, Inc. Quarterly Marketable Securities, Current in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Revolution Medicines, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2019 to Q2 2024.
  • Revolution Medicines, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $1.32B, a 149% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.32B +$786M +149% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.42B +$933M +193% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.16B +$673M +139% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $455M -$21.3M -4.47% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $529M +$174M +48.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $483M +$61.5M +14.6% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $484M +$15M +3.2% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $476M -$3.43M -0.72% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $356M -$95.1M -21.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $421M +$91.1M +27.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $469M +$132M +39.3% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $480M +$78.2M +19.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $451M +$149M +49.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $330M +$165M +99.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $336M +$230M +217% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $401M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $301M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $165M Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $106M Dec 31, 2019 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.